Natural killer cells: a review of manufacturing and clinical utility

Authors

  • Scott A. Koepsell,

    1. From the Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, University of Minnesota Medical School; the Department of Medicine, Division of Hematology, Oncology, and Transplantation, and the Clinical Cell Therapy Laboratory, University of Minnesota Medical Center, Molecular and Cellular Therapeutics; and University of Minnesota Cancer Center, Minneapolis/Saint Paul, Minnesota.
    Search for more papers by this author
  • Jeffrey S. Miller,

    1. From the Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, University of Minnesota Medical School; the Department of Medicine, Division of Hematology, Oncology, and Transplantation, and the Clinical Cell Therapy Laboratory, University of Minnesota Medical Center, Molecular and Cellular Therapeutics; and University of Minnesota Cancer Center, Minneapolis/Saint Paul, Minnesota.
    Search for more papers by this author
  • David H. McKenna Jr

    Corresponding author
    1. From the Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, University of Minnesota Medical School; the Department of Medicine, Division of Hematology, Oncology, and Transplantation, and the Clinical Cell Therapy Laboratory, University of Minnesota Medical Center, Molecular and Cellular Therapeutics; and University of Minnesota Cancer Center, Minneapolis/Saint Paul, Minnesota.
      David H. Jr. McKenna, MD, Clinical Cell Therapy Laboratory, University of Minnesota Medical Center, Molecular & Cellular Therapeutics, 1900 Fitch Avenue, Saint Paul, MN 55108; e-mail: mcken020@umn.edu.
    Search for more papers by this author

David H. Jr. McKenna, MD, Clinical Cell Therapy Laboratory, University of Minnesota Medical Center, Molecular & Cellular Therapeutics, 1900 Fitch Avenue, Saint Paul, MN 55108; e-mail: mcken020@umn.edu.

Ancillary